glycylphenylalanine 2-naphthylamide has been researched along with metrizamide in 1 studies
| Studies (glycylphenylalanine 2-naphthylamide) | Trials (glycylphenylalanine 2-naphthylamide) | Recent Studies (post-2010) (glycylphenylalanine 2-naphthylamide) | Studies (metrizamide) | Trials (metrizamide) | Recent Studies (post-2010) (metrizamide) |
|---|---|---|---|---|---|
| 28 | 0 | 7 | 1,712 | 105 | 5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berg, T; Berg, TO; Løvdal, T; Seglen, O; Strømhaug, E | 1 |
1 other study(ies) available for glycylphenylalanine 2-naphthylamide and metrizamide
| Article | Year |
|---|---|
Use of glycyl-L-phenylalanine 2-naphthylamide, a lysosome-disrupting cathepsin C substrate, to distinguish between lysosomes and prelysosomal endocytic vacuoles.
Topics: Animals; Asialoglycoproteins; Cathepsin C; Cellobiose; Dipeptides; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Endocytosis; Lysosomes; Male; Metrizamide; Orosomucoid; Rats; Rats, Wistar; Subcellular Fractions; Substrate Specificity; Vacuoles; Vinblastine | 1994 |